Quick Listen: Scrip’s Five Must-Know Things
Join us for an audio catch-up on the past week's major events in the global biopharma industry, as brought to you by Scrip's global team, in this mini podcast version of Five Must-Know Things.
This episode includes the main news from around the biopharma world in the business week ended 18 December 2020.
This week, we look at a big deal in immunology, a story of vaccine success, Japan’s vaccine environment, one big pharma firm’s challenges and opportunities, and a disappointment in rheumatoid arthritis.
Stories mentioned in this episode:
(Also see "AZ's Alexion Acquisition Looks Astute Bit Of Business" - Scrip, 13 Dec, 2020.)
(Also see "Pfizer Rose To The COVID-19 Challenge And The Stars Aligned" - Scrip, 11 Dec, 2020.)
(Also see "Pharma Power Japan Barely In COVID Vaccines Race. Why?" - Scrip, 16 Dec, 2020.)
(Also see "AbbVie: Rinvoq And Skyrizi Will Bridge US Humira Sales Erosion Through 2025" - Scrip, 14 Dec, 2020.)
(Also see "Gilead Gives Up On Galapagos's Filgotinib In RA" - Scrip, 16 Dec, 2020.)
These and all Informa Pharma Intelligence podcasts are available on SoundCloud, Apple Podcasts, TuneIn and Google Play and also via smart speakers - just make sure one of these providers is set up as your default for podcasts, and then ask for "Pharma Intelligence podcasts".